Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 7
2002 59
2003 62
2004 70
2005 59
2006 70
2007 69
2008 86
2009 75
2010 97
2011 97
2012 85
2013 71
2014 72
2015 66
2016 57
2017 40
2018 35
2019 16
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,081 results
Results by year
Filters applied: . Clear all
Page 1
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. Cuker A, et al. Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Blood Adv. 2018. PMID: 30482768 Free PMC article.
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
Schindewolf M, Steindl J, Beyer-Westendorf J, Schellong S, Dohmen PM, Brachmann J, Madlener K, Pötzsch B, Klamroth R, Hankowitz J, Banik N, Eberle S, Müller MM, Kropff S, Lindhoff-Last E. Schindewolf M, et al. J Am Coll Cardiol. 2017 Nov 28;70(21):2636-2648. doi: 10.1016/j.jacc.2017.09.1099. J Am Coll Cardiol. 2017. PMID: 29169470 Free article. Clinical Trial.
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Kearon C, et al. Chest. 2012 Feb;141(2 Suppl):e419S-e496S. doi: 10.1378/chest.11-2301. Chest. 2012. PMID: 22315268 Free PMC article.
The clinical use of Fondaparinux: A synthetic heparin pentasaccharide.
Zhang Y, Zhang M, Tan L, Pan N, Zhang L. Zhang Y, et al. Prog Mol Biol Transl Sci. 2019;163:41-53. doi: 10.1016/bs.pmbts.2019.02.004. Epub 2019 Mar 21. Prog Mol Biol Transl Sci. 2019. PMID: 31030756 Review.
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Beyer-Westendorf J, Schellong SM, Gerlach H, Rabe E, Weitz JI, Jersemann K, Sahin K, Bauersachs R; SURPRISE investigators. Beyer-Westendorf J, et al. Lancet Haematol. 2017 Mar;4(3):e105-e113. doi: 10.1016/S2352-3026(17)30014-5. Epub 2017 Feb 16. Lancet Haematol. 2017. PMID: 28219692 Clinical Trial.
1,081 results
Jump to page
Feedback